April 14 (Reuters) - Bonesupport Holding AB BONEX.ST :
* BONESUPPORT ANNOUNCES CERAMENT IN COMBINATION WITH
BISPHOSPHONATE SHOWS PROMISING RESULTS IN PRECLINICAL LONG-TERM
STUDY
* NEW PRECLINICAL DATA(1) HAS BEEN PUBLISHED THAT FURTHER
SUPPORT
BONESUPPORT'S AMBITION TO DEVELOP A COMBINATION PRODUCT OF
COMPANY'S PLATFORM TECHNOLOGY CERAMENT® AND BISPHOSPHONATE, A
PHARMACEUTICAL THAT COUNTERACTS OSTEOPOROSIS
* EVIDENCE FROM LONG-TERM STUDY VALIDATES AND CONFIRMS LOCAL
DELIVERY OF BISPHOSPHONATE IN COMBINATION WITH CERAMENT CAN
REGENERATE CANCELLOUS BONE IN FEMORAL NECK CANAL AND HAS CLEAR
IMPLICATIONS FOR ENHANCING IMPLANT INTEGRATION AND FIXATION IN
FRAGILE BONE
Source text for Eikon: ID:nWkrbjpNnL
Further company coverage: BONEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))